Evidence map›Paper›PMID 35475135›Full record

ReviewBJUI compass2021

Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators.

Beth Russell, Christel Häggström, Lars Holmberg, Fredrik Liedberg, Truls Gårdmark, Richard T Bryan, Pardeep Kumar, Mieke Van Hemelrijck

Abstract readReview
In one paragraph

Review in BJUI compass, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Beth RussellDepartment of Translational Oncology and Urology Research School of Cancer and Pharmaceutical Sciences King's College London London UK.ORCID https://orcid.org/0000-0001-5640-8425
Christel HäggströmDepartment of Surgical Sciences Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0001-6808-4405
Lars HolmbergDepartment of Translational Oncology and Urology Research School of Cancer and Pharmaceutical Sciences King's College London London UK.
Fredrik LiedbergDepartment of Urology Skåne University Hospital Malmö Sweden.
Truls GårdmarkDepartment of Clinical Sciences Danderyd Hospital, Karolinska Institute Stockholm Sweden.
Richard T BryanInstitute of Cancer and Genomic Sciences The University of Birmingham Birmingham UK.ORCID https://orcid.org/0000-0003-2853-4293
Pardeep KumarThe Royal Marsden NHS Foundation Trust London UK.
Mieke Van HemelrijckDepartment of Translational Oncology and Urology Research School of Cancer and Pharmaceutical Sciences King's College London London UK.ORCID https://orcid.org/0000-0002-7317-0858

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To review the current evidence on the relationship between three proposed mediators (comorbidities, hospital type, and treatment delays) for the relationship between socioeconomic status (SES) and bladder cancer survival. Materials and methods: Six different searches using OVID (Medline and Embase) were carried out to collate information available between the proposed mediators with both SES and survival in bladder cancer. This systematic review was conducted according to a pre-defined protocol and in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 49 studies were included in the review across the six searches (one appeared in two searches). There was a wealth of studies investigating the relationship between each of the proposed mediators with survival in bladder cancer patients. In general, a higher SES, lower comorbidities, and a larger hospital volume were all found to be associated with a decreased risk of death in bladder cancer patients. There was, however, a paucity of studies investigating the associations between these mediators and SES in bladder cancer patients. Conclusions: To gain a deeper understanding of the relationship between SES and survival identified in several observational studies, further investigations into the relationship between the proposed mediators and SES are warranted. Moreover, modifiable mediators, eg, treatment delay, highlight the importance of the standardization of clinical care across SES groups for all bladder cancer patients.

Indexed as

bladder cancermediationsocioeconomic statussurvivalsystematic review

Identifiers

PMID35475135
PMCPMC8988826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.